Literature DB >> 648030

Detection of circulating anticomplementary factors in chronic lung diseases.

A M Hilton, M Moore, J M Howat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 648030      PMCID： PMC1541214     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  11 in total

1.  Immune complexes in cystic fibrosis.

Authors:  H McFarlane; A Holzel; P Brenchley; J D Allan; J C Wallwork; B E Singer; B Worsley
Journal:  Br Med J       Date:  1975-02-22

2.  Evidence for circulating immune complexes in thyroid disease.

Authors:  E A Calder; W J Penhale; E W Barnes; W J Irvine
Journal:  Br Med J       Date:  1974-04-06

3.  Competition for receptors for immunoglobulin on cytotoxic lymphocytes.

Authors:  I C MacLennan
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

4.  Circulating immune complexes in dermatitis herpetiformis.

Authors:  J F Mowbray; A V Hoffbrand; E J Holborow; P P Seah; L Fry
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

Review 5.  The alternative pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

6.  Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.

Authors:  V Agnello; R J Winchester; H G Kunkel
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

7.  The reaction of monomeric and aggregated immunoglobulins with C1.

Authors:  W Augener; H M Grey; N R Cooper; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1971-11

8.  Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.

Authors:  A Z Lurhuma; C L Cambiaso; P L Masson; J F Heremans
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

9.  Detection of circulating immune complexes in pathological human sera.

Authors:  A H Johnson; J F Mowbray; K A Porter
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

10.  Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.

Authors:  J Siegel; R Rent; H Gewurz
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307
View more
  5 in total

1.  Studies on the nature of heat-labile anti-complementary activity in normal human serum.

Authors:  R D Soltis; D Hasz; M J Morris; I D Wilson
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

2.  Cutaneous vasculitis and immune complexes in severe bronchiectasis.

Authors:  A M Hilton; P S Hasleton; A Bradlow; B C Leahy; K M Cooper; M Moore
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

3.  Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC).

Authors:  G D Harkiss; D L Brown
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

4.  C1q binding activity in the sera of patients with chronic lung diseases.

Authors:  K M Cooper; M Moore; A M Hilton
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

5.  Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera.

Authors:  J M Howat; M Moore; A M Hilton; I Kimber
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.